We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Alirocumab
Australian Public Assessment Report
Device/Product Name
Praluent
Active ingredients
Alirocumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2016-01950-1-3
Submission Type
Major variation: extension of indications and new dose regimen
Decision
Approved